CIK 0000949858
- Non-accelerated filer
- Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Tickers
- ACHV QUIT
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 954343413
- Phone
- +1 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Securities
- ACHV Common stock Nasdaq
- QUIT Common Shares Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-06 | Duty Stuart Director | Grant or award · Stock Option (right to buy) | +31,500 | 31,500 | ||
| 2024-01-22 | Duty Stuart Director | Grant or award · Stock Option (right to buy) | +31,500 | 31,500 | ||
| 2023-03-29 | Duty Stuart Director | Grant or award · Stock Option (right to buy) | +23,250 | 23,250 | ||
| 2023-03-29 | Duty Stuart Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 |
Page 1 of 1 · 4 trades